[1]
A. Bozdogan, S. Emiroglu, A. Abuaisha, and O. D. Basar, “Risk Factors of Response to Neoadjuvant Chemotherapy in Patients with Luminal (HER2 Negative) Breast Cancer: Roc Curve and Logistic Regression Model Results: RF of response to NAC in HER2- BC”, Arch Breast Cancer, vol. 11, no. 1, pp. 67–74, Jan. 2024.